Product Information
PILOCARPINE HCL 7.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3540 per EA under NDC 59651022501. Its NADAC has been published 269 times since Aug 11, 2021.
FDA first approved this application on Aug 13, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651022501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PILOCARPINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212377FDA Approved
8/13/2019
TE Code
AB
On Market Since
8/13/2019
Pharmacological Classes
Price Statistics
The NADAC for PILOCARPINE HCL 7.5 MG TABLET has been published 269 times since Aug 11, 2021, and over the history we have for it it has declined 65.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3540 per EA |
|---|---|
| All-time high | $1.0885 (Mar 16, 2022) |
| All-time low | $0.3028 (Jun 17, 2026) |
| 52-week high | $0.4379 |
| 52-week low | $0.3028 |
| Median price | $0.5295 |
| Average price | $0.5745 |
| Largest weekly change | +57.7% (Feb 23, 2022) |
| Weeks tracked | 269 |
| Tracking since | Aug 11, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pilocarpine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pilocarpine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PILOCARPINE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PILOCARPINE HCL 7.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.3540 per EA (NDC 59651022501), effective Sep 30, 2026.
How has the price of PILOCARPINE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PILOCARPINE HCL 7.5 MG TABLET has declined 65.8%. It has been tracked across 269 weekly CMS publications since Aug 11, 2021.
What are the highest and lowest recorded NADAC prices for PILOCARPINE HCL 7.5 MG TABLET?
Since Aug 11, 2021, the NADAC for PILOCARPINE HCL 7.5 MG TABLET has ranged from a low of $0.3028 (Jun 17, 2026) to a high of $1.0885 (Mar 16, 2022), with a median of $0.5295 per EA.
Are there cheaper alternatives to PILOCARPINE HCL 7.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PILOCARPINE HCL 7.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PILOCARPINE HCL 7.5 MG TABLET?
PILOCARPINE HCL 7.5 MG TABLET (NDC 59651022501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.